Tvardi Therapeutics (TVRD) Shares Outstanding (Entity) (2013 - 2026)
Tvardi Therapeutics' Shares Outstanding (Entity) came in at 9.38 million for Q2 2026, up 0.1% from 9.37 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) Shares Outstanding (Entity) (2013 - 2026) Analysis & Trends
For FY2025, Tvardi Therapeutics' Shares Outstanding (Entity) was 7.42 million, up 386.9% from FY2024.
- Shares Outstanding (Entity) has increased in each of the last 13 years, with a five-year compound annual growth rate of 39.9% (FY2020 to FY2025).
- Going back by year, Shares Outstanding (Entity) was 1.52 million in FY2024 (+0.7%), 1.51 million in FY2023 (+1.3%), 1.49 million in FY2022 (+0.6%) and 1.49 million in FY2021 (+7.2%).
- Year-over-year, Shares Outstanding (Entity) has increased for 50 consecutive quarters, with growth averaging 241.9% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 0.1% (Q2 2026) to 515.7% (Q3 2025).
- Business Quant data shows TVRD's Shares Outstanding (Entity) at 9.38 million (Q1 2026), 7.42 million (Q4 2025) and 9.38 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 940.75 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 540.90 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Tvardi Therapeutics | 12.48 Mn | -95.62 Mn | - | 9.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.38 Mn |
| Mar 31, 2026 | 9.38 Mn |
| Dec 31, 2025 | 7.42 Mn |
| Sep 30, 2025 | 9.38 Mn |
| Jun 30, 2025 | 9.37 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 1.52 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Mar 31, 2023 | 1.50 Mn |
| Dec 31, 2022 | 1.49 Mn |
| Sep 30, 2022 | 1.49 Mn |
| Jun 30, 2022 | 1.49 Mn |
| Mar 31, 2022 | 1.49 Mn |
| Dec 31, 2021 | 1.49 Mn |
| Sep 30, 2021 | 1.39 Mn |
API Access
Tvardi Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();